322 related articles for article (PubMed ID: 142131)
1. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
Arnesen H
J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
[No Abstract] [Full Text] [Related]
2. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
Rozenfel'd MA; Leonova VB; Khavkina LS
Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
Heene DL; Genth K
Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
[No Abstract] [Full Text] [Related]
4. Biological behavior of higher molecular weight products of fibrinolysis.
Chang ML; Bang NU
J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
[TBL] [Abstract][Full Text] [Related]
5. [Cross-linked fibrin polymer and degradation products by plasmin (XDP)].
Kawai Y
Nihon Rinsho; 2004 Dec; 62 Suppl 12():618-22. PubMed ID: 15658405
[No Abstract] [Full Text] [Related]
6. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
[TBL] [Abstract][Full Text] [Related]
7. Basic Evaluation of the Newly Developed "Lias Auto P-FDP" Assay and the Influence of Plasmin-α2 Plasmin Inhibitor Complex Values on Discrepancy in the Comparison with "Lias Auto D-Dimer Neo" Assay.
Kumano O; Ieko M; Komiyama Y; Naito S; Yoshida M; Takahashi N; Ohmura K; Hayasaki J; Hayakawa M
Clin Lab; 2018 Apr; 64(4):433-442. PubMed ID: 29739066
[TBL] [Abstract][Full Text] [Related]
8. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
Zhitkova IuV; Aĭsina RB; Varfolomeev SD
Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
[TBL] [Abstract][Full Text] [Related]
9. [Nonenzymatic fibrinolysis].
Dzhurdzhev A; Atanasov K
Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
[No Abstract] [Full Text] [Related]
10. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
11. Unreliability of current serum fibrin degradation product (FDP) assays.
Gaffney PJ; Perry MJ
Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii.
Malinconico SM; Katz JB; Budzynski AZ
J Lab Clin Med; 1984 Nov; 104(5):842-54. PubMed ID: 6387015
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of fibrinogen/fibrin degradation products (F/F DP)].
Alakhverdian R
Vutr Boles; 1979; 18(3):160-7. PubMed ID: 89851
[No Abstract] [Full Text] [Related]
14. Evidence that fibrin(ogen) degradation products (FDP) are adequately quantified in citrated plasma defibrinated at low pH.
Godal HC; Hamborg T
Scand J Haematol; 1984 Jan; 32(1):46-8. PubMed ID: 6695150
[TBL] [Abstract][Full Text] [Related]
15. Fibrin degradation products. A review of structures found in vitro and in vivo.
Gaffney PJ
Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
[TBL] [Abstract][Full Text] [Related]
16. [Significance of the laboratory diagnosis of hypercoagulability].
Vorlová Z; Dyr JE
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):450-5. PubMed ID: 6083910
[TBL] [Abstract][Full Text] [Related]
17. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
Bini A; Itoh Y; Kudryk BJ; Nagase H
Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
[TBL] [Abstract][Full Text] [Related]
18. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
Fujimaki M; Ikematsu S; Takeuchi I
Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
[No Abstract] [Full Text] [Related]
19. Problems of diagnosis of disseminated intravascular coagulation (DIC).
Bowie EJ; Owen CA
Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):325-7. PubMed ID: 515796
[TBL] [Abstract][Full Text] [Related]
20. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
Schwartz LB; Bradford TR; Littman BH; Wintroub BU
J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]